McCollum Christoferson Group LLC Has $1.02 Million Stake in The Clorox Company (NYSE:CLX)

McCollum Christoferson Group LLC trimmed its position in shares of The Clorox Company (NYSE:CLX) by 3.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,285 shares of the company’s stock after selling 240 shares during the period. McCollum Christoferson Group LLC’s holdings in Clorox were worth $1,024,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Culbertson A N & Co. Inc. increased its holdings in shares of Clorox by 173.1% in the 3rd quarter. Culbertson A N & Co. Inc. now owns 9,443 shares of the company’s stock valued at $1,538,000 after purchasing an additional 5,985 shares during the period. Vontobel Holding Ltd. grew its position in Clorox by 4.6% during the third quarter. Vontobel Holding Ltd. now owns 27,213 shares of the company’s stock valued at $4,433,000 after purchasing an additional 1,189 shares in the last quarter. ERn Financial LLC acquired a new position in Clorox in the 3rd quarter valued at approximately $224,000. Creative Planning lifted its position in Clorox by 7.4% in the 3rd quarter. Creative Planning now owns 29,089 shares of the company’s stock worth $4,739,000 after buying an additional 1,996 shares in the last quarter. Finally, Fiduciary Alliance LLC acquired a new stake in shares of Clorox during the 3rd quarter valued at $240,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.51% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on CLX shares. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. DA Davidson reaffirmed a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research report on Friday, September 6th. Citigroup lifted their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Finally, Wells Fargo & Company cut their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. Six research analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $150.14.

Clorox Stock Up 0.1 %

Clorox stock opened at $163.43 on Thursday. The firm has a market cap of $20.30 billion, a price-to-earnings ratio of 84.68, a P/E/G ratio of 3.19 and a beta of 0.41. The firm has a fifty day moving average price of $158.53 and a two-hundred day moving average price of $144.98. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. As a group, analysts forecast that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 2.99%. Clorox’s payout ratio is 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.